No they would't have - they were blinded, and don't have 'their own recordings'.
The CEO was upbeat because that is largely the function of a CEO in a biotech company.
You can't blame management for the failure of a clinical trial (assuming it was an appropriately planned and powered trial) - blame tumour biology, and an incomplete understanding of this.
No they would't have - they were blinded, and don't have 'their...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable